Key result
Co-administration of Fc-apelin significantly attenuated LPS-induced serum ALT elevation (47.5 vs 73.8 unit/L, p<0.01) and diminished hepatic apoptosis, ROS production, and macrophage infiltration.
Why the study?
Does Fc-apelin fusion protein attenuate lipopolysaccharide-induced liver injury in mice?
Does Fc-apelin fusion protein attenuate lipopolysaccharide-induced liver injury in mice?
Absolute Event Rate: 47.5% vs 73.8%
p-value: p=<0.01
Fc-apelin fusion protein exerts protective effects against LPS-induced liver damage by reducing apoptosis, oxidative stress, and inflammation, suggesting potential as a therapeutic for endotoxin-induced liver injury.
Merits human trials for sepsis-associated liver injury; novel preclinical finding leaves open clinical translation.
Apelin is a peptide hormone with anti-oxidative and anti-inflammatory activities and is proposed to be a potential therapeutic for many disease conditions, including sepsis. However, short in vivo half-life of the apelin peptide would limit its potential clinical applications. This study aims to investigate the effects of Fc-apelin, a novel long-acting apelin fusion protein, on lipopolysaccharide (LPS)-induced liver injury. Liver injury was induced by systemic injection of LPS in mice. Hepatoprotective activities of Fc-apelin against inflammation were evaluated in LPS mice and/or hepatoma Huh-7 cells with respect to serum ALT, apoptosis, oxidative stress, macrophage infiltration and gene expression. We found that LPS induced systemic inflammation and liver damage. Co-administration of Fc-apelin significantly attenuated serum ALT elevation, diminished LPS-induced apoptosis and ROS production in the liver and in Huh-7 cells, mitigated hepatic macrophage infiltration, and reduced TNFα and IL-6 gene expression. Collectively, Fc-apelin fusion protein exerts protective effects against LPS-induced liver damage and may serve as a potential therapeutic for endotoxin-induced liver injury.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2018) studied LPS-induced liver injury (endotoxemia) (n=36). Fc-apelin fusion protein vs. PBS (vehicle) was evaluated on Serum ALT levels (p=<0.01). Co-administration of Fc-apelin significantly attenuated LPS-induced serum ALT elevation (47.5 vs 73.8 unit/L, p<0.01) and diminished hepatic apoptosis, ROS production, and macrophage infiltration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: